Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
xconomy.com » Xconomy Life Sciences Feed - Nov 11, 2008
Life Sciences, Stem Cells, Proposition 71 Bruce V. Bigelow wrote: It has been seven years since the Bush Administration restricted federal funding on human embryonic stem cells, and four years since California voters …
Also tagged: invitrogen, san diego, stem cells, uc san diego, life sciences, salk institute, san diego blog main, sanford consortium for regenerative medicine, babak esmaeli azad, proposition 71, dnamicroarray inc, floyd bloom, duane roth, the scripps research institure, kenneth chien, histogen, t denny sanford, the burnham institute for biomedical reserch, stemgent
xconomy.com » Xconomy - Nov 10, 2008
Life Sciences, Stem Cells, Proposition 71 Bruce V. Bigelow wrote: It has been seven years since the Bush Administration restricted federal funding on human embryonic stem cells, and four years since California voters …
Also tagged: invitrogen, san diego, stem cells, uc san diego, life sciences, salk institute, san diego blog main, sanford consortium for regenerative medicine, babak esmaeli azad, proposition 71, dnamicroarray inc, floyd bloom, duane roth, the scripps research institure, kenneth chien, histogen, t denny sanford, the burnham institute for biomedical reserch, stemgent
fiercebioresearcher.com » News - Nov 7, 2008
Scientists at Boston's Children's Hospital have discovered a way to regenerate damaged nerve cells. In the mouse study, published in the November 7 issue of Science, researchers found that silencing the PTEN and TSC1 …
Also tagged: brain cells
thaindian.com » Thaindian News - Oct 31, 2008
Washington, Oct 31 (ANI): Taking a crucial step towards stem cell therapies, scientists have revealed that our bodies” ability to respond to an internal ”mayday” signal may ultimately pave the way for long-awaited …
Also tagged: heart attack, heart disease, stem cells, health science, stem cell, blood vessel growth, blood vessels, mayday, heart muscle, heart attack patients, blood supply, university of bristol, new blood, chemical messengers, muddle, distress call, cell population, oxygen supply, nicolle, target tissue
 |
Pervasis, Maker of Product to Heal Blood Vessels, Hires Genzyme Exec as First CEOxconomy.com » Xconomy Life Sciences Feed - Oct 22, 2008 Biotech, Regenerative Medicine, tissue engineering Luke Timmerman wrote: Pervasis Therapeutics, a Cambridge, MA-based cell therapy company, has hired a veteran businessman from Genzyme as its first CEO. Frederic … Also tagged: biotech, boston, mit, life sciences, genzyme, tissue engineering, polaris venture partners, highland capital partners, robert langer, boston blog main, flagship ventures, national blog main, pervasis, american society of nephrology, frederic chereau, vascugel |
|
Pervasis, Maker of Product to Heal Blood Vessels, Hires Genzyme Exec as First CEOxconomy.com » Xconomy Boston - Oct 21, 2008 Biotech, Regenerative Medicine, tissue engineering Luke Timmerman wrote: Pervasis Therapeutics, a Cambridge, MA-based cell therapy company, has hired a veteran businessman from Genzyme as its first CEO. Frederic … Also tagged: biotech, boston, mit, life sciences, genzyme, tissue engineering, polaris venture partners, highland capital partners, robert langer, boston blog main, flagship ventures, national blog main, pervasis, american society of nephrology, frederic chereau, vascugel |
fiercehealthcare.com » News - Sep 24, 2008
In recent years, research based on embryonic stem cells has led to a great deal of controversy. However, increasingly, researchers are finding techniques that may allow them to turn average cells into cells with the …
Also tagged: pfizer, stem cell research
xconomy.com » Xconomy Life Sciences Feed - Aug 29, 2008
Biotech, Multiple Sclerosis, Life Sciences Luke Timmerman wrote: Biogen Idec has made a lot of its money on Avonex and Tysabri, drugs that slow down the rate of flare-ups for people with multiple sclerosis. Now the …
Also tagged: drugs, biotech, boston, multiple sclerosis, cleveland clinic, wyeth, nature medicine, myelin, life sciences, avonex, tysabri, lingo 1, boston blog main, national blog main, bruce trapp, genetics institute, sha mi, kenneth rhodes
xconomy.com » Xconomy Boston - Aug 28, 2008
Biotech, Multiple Sclerosis, Life Sciences Luke Timmerman wrote: Biogen Idec has made a lot of its money on Avonex and Tysabri, drugs that slow down the rate of flare-ups for people with multiple sclerosis. Now the …
Also tagged: drugs, biotech, boston, multiple sclerosis, cleveland clinic, wyeth, nature medicine, myelin, life sciences, avonex, tysabri, lingo 1, boston blog main, national blog main, bruce trapp, genetics institute, sha mi, kenneth rhodes
xconomy.com » Xconomy - Aug 27, 2008
Biotech, Multiple Sclerosis, Life Sciences Luke Timmerman wrote: Biogen Idec has made a lot of its money on Avonex and Tysabri, drugs that slow down the rate of flare-ups for people with multiple sclerosis. Now the …
Also tagged: drugs, biotech, boston, multiple sclerosis, cleveland clinic, wyeth, nature medicine, myelin, life sciences, avonex, tysabri, lingo 1, boston blog main, national blog main, bruce trapp, genetics institute, sha mi, kenneth rhodes